EDIT vs WFC · rev $32.3M vs P/E 15, $272.05B cap
Editas Medicine Inc (EDIT) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
WFC does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the EDIT and WFC stock pages for the full models.
Not investment advice.